MedTrace Logo

Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function

NCT03716609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-01-26

No results posted yet for this study

Summary

Using a double-blind randomized controlled trial design, this study intends to evaluate the short-term effect of magnesium citrate on cognitive functions and hemodynamic parameters in MCI elders, including Montreal Cognitive Assessment, working memory test-digit span test, carotid artery flow velocity, ankle-brachial blood pressure ratio, and urinary magnesium.

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Magnesium Citrate

Pure Magnesium citrate powder 2.07 gram from NOW FOODS (Bloomingdale, IL, USA)

OTHER

Food grade citrate acid

Food grade citrate acid 0.1 gram from San Fu Chemical Co., Ltd (Taipei, Taiwan)

OTHER

Splenda(Sucralose)

Splenda 1.0 gram from Splenda(Carmel, Indiana, USA)

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • Academia Sinica, Taiwan

    lead OTHER

Principal Investigators

  • Wen-Harn Pan, Ph.D. · Institute of Biomedical Sciences, Academia Sinica

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-23
Primary Completion
2019-06-30
Completion
2021-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03716609 on ClinicalTrials.gov